Related Experiment Video

Updated: Jun 10, 2025

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

3.3K

TRIP13: A promising cancer immunotherapy target

Shengnan Jing1, Liya Zhao1, Liwen Zhao1

  • 1Institute of Pain Medicine and Special Environmental Medicine, Co-innovation Center of Neuroregeneration Nantong University Nantong Jiangsu China.

Cancer Innovation
|October 14, 2024
PubMed

Insights

Thyroid hormone receptor interactor 13 (TRIP13) promotes tumor growth and immune suppression. Inhibiting TRIP13 may enhance anti-cancer immune responses and improve immunotherapy efficacy.

Area of Science:

  • Oncology
  • Immunology
  • Molecular Biology

Background:

  • The tumor microenvironment (TME) supports tumor progression and immune evasion.
  • Thyroid hormone receptor interactor 13 (TRIP13) is an AAA+ ATPase involved in cellular signaling and tumor progression.
  • Emerging evidence links TRIP13 to immune suppression within the TME.

Purpose of the Study:

  • To review the role of TRIP13 in cancer development and immune modulation.
  • To discuss the potential of TRIP13 as a therapeutic target for enhancing cancer immunotherapy.

Main Methods:

  • Literature review of recent studies on TRIP13 function in cancer.
  • Analysis of TRIP13's involvement in tumor growth, metastasis, and immune suppression.
  • Evaluation of TRIP13's potential as a target for immune checkpoint inhibition.

Main Results:

  • TRIP13 influences key cancer processes including proliferation, invasion, migration, and metastasis.
  • TRIP13 actively suppresses immune responses within the tumor microenvironment.
  • Targeting TRIP13 presents a promising strategy to augment anti-tumor immunity.

Conclusions:

  • TRIP13 is a critical regulator of the tumor microenvironment and immune evasion.
  • Inhibition of TRIP13 holds potential for improving the efficacy of immune-based cancer therapies.
  • Further research into TRIP13 inhibition could lead to novel therapeutic strategies for cancer patients.
Keywords:
immune responsesimmune‐based therapiesthyroid hormone receptor interactor 13tumor microenvironment

More Related Videos

Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer07:55

Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer

Published on: January 17, 2025

673
A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy09:56

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

464

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
488
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
342
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.5K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K